Vanderbilt University’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,959
Closed -$124K 57
2023
Q2
$124K Sell
1,959
-980
-33% -$59.4K 0.03% 46
2023
Q1
$99.8K Buy
+2,939
New +$154K 0.02% 47

Other funds holding CDLX

Vanderbilt University's CDLX Position: Q3 2023 in Review

Vanderbilt University sold out of Cardlytics (CDLX) in Q3 2023, closing a stake of 1,959 shares — an estimated $124K sold.

Vanderbilt University first reported a position in CDLX in Q1 2023 and held it in 2 quarters. The position peaked at $124K in Q2 2023. 112 funds tracked by Wall St. Rank hold CDLX as of Q3 2023.

  • Vanderbilt University reported no remaining Cardlytics position as of Q3 2023 after selling out during the quarter.
  • Vanderbilt University sold 1,959 Cardlytics shares in Q3 2023, an estimated $124K.
  • Vanderbilt University first reported a position in Cardlytics in Q1 2023 and held it in 2 quarters.
  • Vanderbilt University's Cardlytics position peaked at $124K in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Cardlytics as of Q3 2023.

Based on Vanderbilt University's 13F filing for Q3 2023, filed 16 Oct 2023.